ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
7.62
+0.12 (1.53%)
Jun 8, 2026, 11:49 AM EDT - Market open
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $788.29 million as of June 8, 2026. Its market cap has increased by 88.91% in one year.
Market Cap
788.29M
Enterprise Value
501.18M
1-Year Change
88.91%
Ranking
Category
Stock Price
$7.62
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $788.29M, an increase of 6.24%. That is a compound annual growth rate of 0.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 776.38M | -2.54% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 833.49M |
| Cullinan Therapeutics | 830.30M |
| LB Pharmaceuticals | 818.14M |
| Janux Therapeutics | 814.75M |
| Phathom Pharmaceuticals | 804.63M |
| Replimune Group | 781.96M |
| Kura Oncology | 775.89M |
| Odyssey Therapeutics | 775.07M |